Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
Genuine Parts Q3 Earnings: Industrial Weakness And Europe Drag On Profit, Margins Shrink, Lowers Annual Outlook
October 22, 2024
From Benzinga
T-Mobile Sparks Autonomous Vehicle Revolution: 5G Network Fuels Jacksonville's Futuristic Shuttle System
October 22, 2024
From Benzinga
Logitech Q2 Sales Beats By A Whisker, Ups FY25 Sales Forecast But Lags Behind Expectations
October 22, 2024
From Benzinga
Marlboro Maker Philip Morris Highlights Strong Q3 Performance On Higher Prices, Issues Upbeat Annual Forecast
October 22, 2024
From Benzinga
From Benzinga
Pentair Beats Q3 Estimates, Raises Profit Outlook As CEO Credits 'Strong Execution'
October 22, 2024
From Benzinga
RTX Lifts 2024 Outlook, Beats Q3 Expectations On Strong Defense And Commercial Growth
October 22, 2024
From Benzinga
From Benzinga
Post-It Maker 3M Q3 Earnings: Sales Growth Slows, Margins Expand, Raises Annual Profit Outlook
October 22, 2024
From Benzinga
General Motors Q3 Earnings: Revenue And EPS Beat, Raises Annual Profit Outlook On Growing Consumer Demand
October 22, 2024
From Benzinga
Verizon Q3 Earnings: Wireless Subs Boost with 5G Offers, $1.7B Severance Charge Hit To Profit, Reiterates Annual Outlook
October 22, 2024
From Benzinga
From Benzinga
Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance
October 22, 2024
From Benzinga
Asia Mixed, Europe Slips, Gold Near Record High - Global Markets Today While US Slept
October 22, 2024
From Benzinga
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
October 21, 2024
From Benzinga
Nvidia Joins Big Tech Hyperscalers At HLTH Conference, Partners With Microsoft To Drive AI Innovations
October 21, 2024
From Benzinga
From Benzinga
Warby Parker Shines, Canada Goose Slips: Goldman Sachs Adjusts Ratings On Apparel Sector Giants
October 21, 2024
From Benzinga
From Benzinga
Salesforce Cuts Wait Times In Healthcare, New Collaboration Transforms Prior Authorizations
October 21, 2024
From Benzinga
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
October 21, 2024
From Benzinga
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
October 21, 2024
From Benzinga
GitLab Sees Surge in 'Ultimate' Adoption and Enterprise Demand, Analyst Upgrades Stock
October 21, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Viad Shakes Things Up With $535M GES Sale, Rebranding Ahead
October 21, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
